For a growing number of UK consumers, the weekly food shop has become smaller, but more considered.
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro suppress appetite, reduce calorie intake and are changing how people eat day to day.
According to data from IGD, sales of these GLP-1 (glucagon-like peptide) medications rose from 3.1% to 4.2% of UK adults between June and September 2025, with 11% now saying they would consider taking them.
And the trend is starting to ripple through the grocery sector. From reduced snacking and meal sizes to stronger demand for fresh food and protein-rich meals, supermarkets and brands are quietly rethinking what belongs in the basket and what no longer does.
Grocery Gazette sat down with British Nutrition Foundation nutrition scientist Bridget Benelam and IGD shopper insights manager Caroline Young to discuss this new trend and how it is impacting the supermarket shelf.
